SCHEMBL9953802

SCHEMBL9953802

COc1ccc(C(C=NO)c2cc(Br)ccn2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC10A1 Q14973 1/20 0.34
CYP19A1 P11511 2/20 0.33
AHR P35869 1/20 0.33
DYRK1A Q13627 2/20 0.33
BACE1 P56817 1/20 0.32
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
MAPT P10636 4/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32
TDP1 Q9NUW8 3/20 0.32
USP2 O75604 1/20 0.32
CYP3A4 P08684 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
ALOX12 P18054 1/20 0.32
MAPK1 P28482 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CCR5 P51681 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2008368 0.83 S1PR1 (0.34) CYP19A1S1PR1S1PR3KDM4EALDH1A1
SCHEMBL2011686 0.83 S1PR1 (0.36) CYP19A1S1PR1S1PR3KDM4EALDH1A1
SCHEMBL17981886 0.75 DYRK1A (0.37) SLC10A1CYP19A1AHRDYRK1ABACE1
SCHEMBL30637677 0.73 KDM4E (0.42) S1PR1S1PR3MAPTKDM4EALDH1A1
SCHEMBL7141858 0.70 NFE2L2 (0.39) AHRMAPTKDM4EALDH1A1TDP1
SCHEMBL16877191 0.70 RIOK2 (0.40) S1PR1S1PR3KDM4EALDH1A1RIOK2
SCHEMBL6182309 0.69 CYP1A2 (0.53) MAPTKDM4EALDH1A1TDP1USP2
SCHEMBL28708881 0.66 ALDH1A1 (0.44) MAPTALDH1A1TDP1HPGDMAPK1
SCHEMBL8025197 0.66 AOC3 (0.43) MAPTALDH1A1TDP1HPGDMAPK1
SCHEMBL30637615 0.65 NR3C2 (0.44) KDM4EALDH1A1MAPK1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655362-A1 HEPATITIS C INHIBITORS AND USES THEREOF Abbvie Inc. (US) 2013-10-30 EP disclosed
WO-2012087833-A1 HEPATITIS C INHIBITORS AND USES THEREOF ABBOTT LABORATORIES (US) 2012-06-28 WO disclosed